
April 4, 2018 Research and Development Cancer, epidermal growth factor, lung cancer, pharma, tumour necrosis factor

April 4, 2018 Research and Development, Sales and Marketing P&G, Pfizer, Procter & Gamble, biotech, drugs, pharma, pharmaceutical

April 4, 2018 Research and Development, Sales and Marketing Allogene, Pfizer, biotech, drugs, pharma, pharmaceutical

April 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

March 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

March 28, 2018 Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

March 28, 2018 Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma

March 28, 2018 Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break

March 28, 2018 Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

March 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

March 27, 2018 Research and Development biotech, drugs, pharma, pharmaceutical

March 27, 2018 Manufacturing and Production, Research and Development Allergan, Biohaven, CGRP, biotech, drugs, migraine, pharma, pharmaceutical

March 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma